Laurus Labs, a leading research and development driven pharmaceutical company in India, which came up with an IPO in India recently, would list its equity shares on the exchanges from Mon, Dec 19, 2016
The issue price for the IPO has been fixed at the upper end of the price band, i.e. at Rs.428 per equity share. The company has raised Rs 1,332 crores through initial public offering that was open for subscription during Dec 6 to Dec 8
The pharma player plans to utilise the net proceeds from the fresh issue towards pre-payment of loans and general corporate purposes. Stay tuned to Indian IPO Blog for live updates on Laurus Labs Listing
The issue price for the IPO has been fixed at the upper end of the price band, i.e. at Rs.428 per equity share. The company has raised Rs 1,332 crores through initial public offering that was open for subscription during Dec 6 to Dec 8
The pharma player plans to utilise the net proceeds from the fresh issue towards pre-payment of loans and general corporate purposes. Stay tuned to Indian IPO Blog for live updates on Laurus Labs Listing
No comments:
Post a Comment